Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1980 1
1982 1
1983 2
1987 1
1988 1
1989 1
1990 2
1993 3
1994 1
1995 2
1996 1
1997 1
1999 1
2000 1
2004 1
2005 4
2006 1
2007 1
2009 1
2010 3
2011 1
2012 1
2014 1
2015 3
2016 1
2020 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.
West NE, Konstan MW, Flume PA, VanDevanter DR, Magaret A, Mazurek H, Amelina EL, Laki I, Chiron R, Sutharsan S, Columbo C, Dorkin HL, Downey DG, Sole A, Hjelte L, Tullis E, Dgetluck N, Dinh Q, Constantine S, White B, Elborn JS, Chmiel JF; JBT101-CF-002 Study Group. West NE, et al. Among authors: dorkin hl. J Cyst Fibros. 2025 Jul;24(4):691-697. doi: 10.1016/j.jcf.2025.03.015. Epub 2025 May 26. J Cyst Fibros. 2025. PMID: 40425421 Clinical Trial.
Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.
Gaggar A, Chen J, Chmiel JF, Dorkin HL, Flume PA, Griffin R, Nichols D, Donaldson SH. Gaggar A, et al. Among authors: dorkin hl. J Cyst Fibros. 2016 Mar;15(2):227-33. doi: 10.1016/j.jcf.2015.07.009. Epub 2015 Aug 28. J Cyst Fibros. 2016. PMID: 26321218 Free PMC article. Clinical Trial.
Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.
Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ. Meissner HC, et al. Among authors: dorkin hl. Pediatr Infect Dis J. 1999 Mar;18(3):223-31. doi: 10.1097/00006454-199903000-00004. Pediatr Infect Dis J. 1999. PMID: 10093942 Review. No abstract available.
38 results